Author: Caspian Hartwell - Page 2

Prescriber Attitudes Toward NTI Drugs and Substitution: What Doctors Really Think +
17 Jan

Prescriber Attitudes Toward NTI Drugs and Substitution: What Doctors Really Think

Prescribers remain cautious about substituting generic drugs for narrow therapeutic index medications due to risks of instability and adverse effects. Despite FDA assurances, doctors prioritize patient safety through careful monitoring and controlled switching.

Preparing for Kidney Transplant: Evaluation, Waitlist, and Living Donors +
16 Jan

Preparing for Kidney Transplant: Evaluation, Waitlist, and Living Donors

Learn the real steps to get evaluated, waitlisted, and approved for a kidney transplant, including what tests you’ll face, how living donors work, and why so many people get delayed or turned down.

Best Digital Tools for Patient Education: Apps and E-Learning Platforms in 2026 +
14 Jan

Best Digital Tools for Patient Education: Apps and E-Learning Platforms in 2026

Discover the best free digital tools and e-learning platforms for patient education in 2026. Learn how apps like Khan Academy Health, MyTherapy, and Snorkl help patients understand conditions, track symptoms, and improve outcomes-without tech stress.

Uveitis: Eye Inflammation, Causes, and Steroid Therapy +
13 Jan

Uveitis: Eye Inflammation, Causes, and Steroid Therapy

Uveitis is a serious eye inflammation that can lead to vision loss if untreated. Learn the types, causes, and why steroid therapy is critical for protecting your sight.

How Generic Drugs Save Billions in the U.S. Healthcare System +
12 Jan

How Generic Drugs Save Billions in the U.S. Healthcare System

Generic drugs save the U.S. healthcare system nearly $500 billion annually by providing the same effectiveness as brand-name medications at a fraction of the cost. Discover how generics and biosimilars are reshaping drug pricing and what you can do to save money.

Pharmacist Responsibility for Reporting Generic Drug Problems +
11 Jan

Pharmacist Responsibility for Reporting Generic Drug Problems

Pharmacists play a critical role in spotting and reporting generic drug problems like therapeutic inequivalence and manufacturing issues. Though not legally required in most states, reporting adverse events to the FDA through MedWatch is a professional obligation that protects patient safety.

End-Stage Renal Disease: Dialysis, Transplant, and Quality of Life +
10 Jan

End-Stage Renal Disease: Dialysis, Transplant, and Quality of Life

End-stage renal disease requires dialysis or transplant to survive. Transplant offers better survival, fewer restrictions, and higher quality of life-but access remains unequal. Learn the facts, options, and how to advocate for yourself.

How Media Coverage Undermines Confidence in Generic Drugs +
8 Jan

How Media Coverage Undermines Confidence in Generic Drugs

Despite being just as safe and effective as brand-name drugs, generics face widespread public mistrust fueled by misleading media coverage. Learn how news stories shape perceptions - and what can be done to restore confidence.

Hatch-Waxman Amendments: How Landmark Law Created the Modern Generic Drug Market +
7 Jan

Hatch-Waxman Amendments: How Landmark Law Created the Modern Generic Drug Market

The Hatch-Waxman Act of 1984 created the modern system for generic drugs in the U.S., balancing innovation incentives with affordable access. It cut approval costs by 90%, boosted generic use to 90% of prescriptions, and sparked ongoing debates over drug pricing.

Dry Eye Syndrome: Understanding Tear Deficiency and How Artificial Tears Help +
5 Jan

Dry Eye Syndrome: Understanding Tear Deficiency and How Artificial Tears Help

Dry eye syndrome isn't just about dryness-it's a complex tear film problem. Learn how tear deficiency and evaporative dry eye differ, why artificial tears work for some but not others, and what to do when drops aren't enough.